08:00–8:45		Meet the Expert Sessions 11–15
08:00	M11	HIV
		Blandine Denis, France & Nelesh Govender (FECMM), South Africa
08:00	M12	Environment
		Ester Segal, FECMM, Israel & Raquel Sabino, FECMM, Portugal
08:00	M13	Diagnostics/Imaging
		Frédéric Lamoth, FECMM, France & Christopher Thornton, UK
08:00	M14	Resistance
		Maiken Arendrup, Denmark & Lewis White, FECMM, UK
08:00	M15	Registries
		Danila Seidel, Germany & Oscar Marchetti, Switzerland
08:50–10:00		Plenary Session 6—Management of IFD in Pediatrics (EPMyN)
		Chairs: Adilia Warris, FECMM, United Kingdom & Andreas Groll, FECMM, Germany
08:50	PS6.1	Biomarker-Based Diagnostic Work-Up of IFD in Immunocompromised Pediatric Patients
		Thomas Lehrnbecher, Germany
09:20	PS6.2	Pre-Emptive Versus Empiric Antifungal Therapy in Children with Cancer
		Maria Elena Santolaya, Chile
09:50	PS6.3*	Invasive Mucormycosis in Children with Hematological Malignancies and Solid Tumors: Report from the Infection Working Group of the Hellenic Society of Pediatric Hematology Oncology (2008–2017).
		Emmanuel Roilides, Greece
10:30–11:15		Plenary Session 7—Superficial and Dermatology
		Chairs: Arnaldo Colombo, FECMM, Brazil & Yee-Chun Chen, Taiwan, Province of China
10:30	PS7.1	When the Skin Is the Portal of Invasive Infections
		Yee-Chun Chen, Taiwan, Province of China
11:00	PS7.2	When the Skin Talks for Systemic Infections
		Fanny Lanternier, FECMM, France
11:15–12:30		Plenary Session 8—New (Antineoplastic) Drugs, New Risks
		Chairs: Livio Pagano, FECMM, Italy & Johan Maertens, FECMM Belgium
11:30	PS8.1	In Hematology
		Alessandro Busca, Italy
12:00	PS8.2	In Oncology
		Lubos Drgona, FECMM, Slovakia
12:30		Closing TIMM-9